Unity Biotechnology, Inc. (UBX)
Largest Insider Buys in Sector
UBX Stock Price History Chart
UBX Stock Performance
About Unity Biotechnology, Inc.
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular degeneration, and diabetic retinopathy. It also develops UBX1967 for the treatment of ophthalmologic diseases; UBX2050, a human anti-Tie2 agonist monoclonal antibody for the treatment of age-related eye diseases; and UBX2089, a a-Klotho hormone drug candidate for multiple neurology indications. The company was formerly known as Forge, Inc. and changed its name to Unity Biotechnology, Inc. in January 2015. Unity Biotechnology, Inc. was incorporated in 2009 and is headquartered in South San Francisco, California.
Insider Activity of Unity Biotechnology, Inc.
Over the last 12 months, insiders at Unity Biotechnology, Inc. have bought $0 and sold $20,876 worth of Unity Biotechnology, Inc. stock.
On average, over the past 5 years, insiders at Unity Biotechnology, Inc. have bought $56,956 and sold $2.25M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 6,400 shares for transaction amount of $56,956 was made by David Nathaniel E (President) on 2020‑06‑05.
List of Insider Buy and Sell Transactions, Unity Biotechnology, Inc.
| 2024-06-25 | Sale | Ghosh Anirvan | Chief Executive Officer | 1,214 0.0072% | $1.40 | $1,700 | -1.43% | |
| 2024-06-25 | Sale | Sullivan Lynne Marie | CFO & Head of Corp. Dev. | 324 0.0019% | $1.40 | $454 | -1.43% | |
| 2024-06-25 | Sale | Nguyen Alexander Hieu | Chief Legal Officer | 78 0.0005% | $1.40 | $109 | -1.43% | |
| 2024-05-02 | Sale | Ghosh Anirvan | Chief Executive Officer | 603 0.0034% | $1.55 | $935 | -4.91% | |
| 2024-02-02 | Sale | Ghosh Anirvan | Chief Executive Officer | 680 0.0041% | $1.71 | $1,163 | -10.80% | |
| 2024-01-30 | Sale | Ghosh Anirvan | Chief Executive Officer | 1,183 0.0072% | $1.71 | $2,023 | -7.65% | |
| 2023-11-02 | Sale | Ghosh Anirvan | Chief Executive Officer | 589 0.0037% | $1.83 | $1,078 | -16.41% | |
| 2023-10-30 | Sale | Ghosh Anirvan | Chief Executive Officer | 1,024 0.0069% | $1.90 | $1,946 | -13.54% | |
| 2023-09-14 | Sale | Ghosh Anirvan | Chief Executive Officer | 1,246 0.0085% | $2.47 | $3,078 | -30.75% | |
| 2023-08-02 | Sale | Ghosh Anirvan | Chief Executive Officer | 581 0.0043% | $2.94 | $1,708 | -36.23% | |
| 2023-07-31 | Sale | Ghosh Anirvan | Chief Executive Officer | 1,020 0.0075% | $2.86 | $2,917 | -36.46% | |
| 2023-06-26 | Sale | Ghosh Anirvan | Chief Executive Officer | 1,177 0.0085% | $3.20 | $3,766 | -41.48% | |
| 2023-06-14 | Sale | Ghosh Anirvan | Chief Executive Officer | 1,212 0.0087% | $3.39 | $4,109 | -44.71% | |
| 2023-05-02 | Sale | Ghosh Anirvan | Chief Executive Officer | 588 0.004% | $2.17 | $1,276 | -13.06% | |
| 2023-05-01 | Sale | Ghosh Anirvan | Chief Executive Officer | 1,020 0.007% | $2.15 | $2,193 | -11.82% | |
| 2023-03-31 | Sale | Ghosh Anirvan | Chief Executive Officer | 1,959 0.0143% | $1.70 | $3,330 | +23.56% | |
| 2023-03-31 | Sale | Dananberg Jamie | Chief Medical Officer | 420 0.0031% | $1.70 | $714 | +23.56% | |
| 2023-03-14 | Sale | Ghosh Anirvan | Chief Executive Officer | 1,210 0.0081% | $4.00 | $4,840 | -50.30% | |
| 2023-03-14 | Sale | Dananberg Jamie | Chief Medical Officer | 1,005 0.0067% | $4.00 | $4,020 | -50.30% | |
| 2023-02-02 | Sale | Ghosh Anirvan | Chief Executive Officer | 2,573 0.0181% | $4.84 | $12,453 | -49.06% |
Institutional Investor Ownership
| Arch Venture Management Llc | $1.65M | 5.99 | 1M | 0% | +$0 | 2.34 | |
| Alyeska Investment Group L P | $1.51M | 5.48 | 920,013 | -11.65% | -$198,961.48 | 0.01 | |
| The Vanguard Group | $914,059.00 | 3.32 | 557,353 | -0.76% | -$6,968.36 | <0.0001 | |
| Geode Capital Management | $220,035.00 | 0.8 | 134,133 | +1.78% | +$3,856.64 | <0.0001 | |
| Mayo Clinic | $203,493.00 | 0.74 | 124,081 | 0% | +$0 | 3.43 | |
| BlackRock | $184,219.00 | 0.67 | 112,329 | -0.67% | -$1,233.28 | <0.0001 | |
| Renaissance Technologies | $175,000.00 | 0.64 | 106,941 | +180.16% | +$112,536.35 | <0.0001 | |
| Citadel Advisors LLC | $153,489.00 | 0.56 | 93,591 | +92.27% | +$73,660.49 | <0.0001 | |
| Ubs Oconnor Llc | $115,451.00 | 0.42 | 70,397 | -24.06% | -$36,576.89 | 0.01 | |
| Bridgeway Capital Management | $82,000.00 | 0.3 | 50,000 | 0% | +$0 | <0.01 | |
| Founders Fund V Management Llc | $80,642.00 | 0.29 | 49,172 | 0% | +$0 | 0.04 | |
| Wells Fargo | $71,374.00 | 0.26 | 43,521 | +0.04% | +$27.88 | <0.0001 | |
| Cercano Management Llc | $67,630.00 | 0.25 | 41,238 | 0% | +$0 | <0.01 | |
| State Street | $62,031.00 | 0.23 | 37,824 | 0% | +$0 | <0.0001 | |
| Millennium Management LLC | $61,848.00 | 0.23 | 37,712 | +180.64% | +$39,809.57 | <0.0001 | |
| Morgan Stanley | $61,352.00 | 0.22 | 37,410 | +1.77% | +$1,065.99 | <0.0001 | |
| Northern Trust | $37,030.00 | 0.13 | 22,579 | +4.35% | +$1,543.26 | <0.0001 | |
| CAPTRUST | $29,299.00 | 0.11 | 17,865 | New | +$29,299.00 | <0.0001 | |
| Susquehanna International Group | $26,962.00 | 0.1 | 16,440 | +3.02% | +$790.49 | <0.0001 | |
| Squarepoint Ops LLC | $22,858.00 | 0.08 | 13,938 | New | +$22,858.00 | <0.0001 | |
| Endowment Wealth Management Inc | $22,132.00 | 0.08 | 13,495 | New | +$22,132.00 | 0.02 | |
| Advisor Group Holdings Inc | $21,453.00 | 0.08 | 13,085 | -0.92% | -$198.38 | <0.0001 | |
| Cibc Asset Management Inc | $17,440.00 | 0.06 | 10,634 | 0% | +$0 | <0.0001 | |
| LINSCO PRIVATE LEDGER CORP | $17,146.00 | 0.06 | 10,455 | New | +$17,146.00 | <0.0001 | |
| Steward Partners Investment Advisory LLC | $10,403.00 | 0.04 | 6,343 | New | +$10,403.00 | <0.0001 | |
| Tower Research Capital | $8,055.00 | 0.03 | 4,912 | +102.31% | +$4,073.42 | <0.0001 | |
| UBS | $5,730.00 | 0.02 | 3,494 | -62.43% | -$9,521.57 | <0.0001 | |
| Simplex Trading Llc | $2,000.00 | 0.01 | 1,614 | -30.22% | -$866.17 | <0.0001 | |
| JPMorgan Chase | $444.00 | <0.01 | 271 | +5.45% | +$22.94 | <0.0001 | |
| SignatureFD | $328.00 | <0.01 | 200 | 0% | +$0 | <0.0001 | |
| Carmichael Hill & Associates | $164.00 | <0.01 | 100 | 0% | +$0 | <0.0001 | |
| Ameritas Investment Partners Inc | $164.00 | <0.01 | 100 | 0% | +$0 | <0.0001 | |
| Royal Bank of Canada | $0 | <0.01 | 141 | -69.41% | -$0 | <0.0001 | |
| RhumbLine Advisers | $211.00 | <0.01 | 129 | 0% | +$0 | <0.0001 | |
| Fidelity Investments | $16.00 | <0.01 | 10 | -72.97% | -$43.20 | <0.0001 | |
| AllSquare Wealth Management, LLC | $90.00 | <0.01 | 55 | 0% | +$0 | <0.0001 | |
| Qube Research & Technologies | $30.00 | <0.01 | 18 | 0% | +$0 | <0.0001 |